Maxcyte (MXCT) Other Non-Current Assets (2020 - 2026)
Maxcyte's (MXCT) quarterly Other Non-Current Assets came in at $2.6 million in Q1 2026, up 36.37% year-on-year from $1.9 million in Q1 2025, and up 5.63% on a QoQ basis from $2.5 million in Q4 2025.
Maxcyte (MXCT) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has 7 years of Other Non-Current Assets data on file, last reported at $2.6 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 36.37% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $2.6 million, a 36.37% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, up 61.03% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $2.6 million, up from $2.5 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for MXCT reached as high as $2.8 million in Q2 2025 and fell as low as $295000.0 in Q1 2024.
- Historically, Other Non-Current Assets has averaged $1.3 million across 5 years, with a median of $1.1 million in 2024.
- Across the five-year window, Other Non-Current Assets plunged 62.15% in 2023 and surged 547.8% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $809000.0 in 2022, then slumped by 52.04% to $388000.0 in 2023, then jumped by 294.85% to $1.5 million in 2024, then jumped by 61.03% to $2.5 million in 2025, then increased by 5.63% to $2.6 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.6 million in Q1 2026, $2.5 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 285.90 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.25 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 164.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 828.89 Mn |
| 10 | Maxcyte | 110.62 Mn | 110.62 Mn | 8.08 Mn | 2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.61 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 640,000.00 |
| Mar 31, 2024 | 295,000.00 |
| Dec 31, 2023 | 388,000.00 |
| Sep 30, 2023 | 619,400.00 |
| Jun 30, 2023 | 597,300.00 |
| Mar 31, 2023 | 399,300.00 |
| Dec 31, 2022 | 809,000.00 |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 920,500.00 |
| Mar 31, 2022 | 1.05 Mn |
| Dec 31, 2021 | 316,700.00 |
| Sep 30, 2021 | 318,100.00 |
| Jun 30, 2021 | 1.70 Mn |